FeesSafety
Pluang+

Phillips Edison reports Q3 2026 net income of $62.7M, raises full-year earnings guidance with strong rent growth and acquisitions.

Company Fundamentals
26 Oct 2026, 23:14 WIB
GlobeNewsWire
View Source
Bullish
Phillips Edison reports Q3 2026 net income of $62.7M, raises full-year earnings guidance with strong rent growth and acquisitions.

Phillips Edison & Company reported a net income of $62.7 million for Q3 2026, up from $24.7 million in Q3 2025, driven by strong leasing activity and rent growth in its grocery-anchored shopping centers. The company increased its full-year 2026 earnings guidance, expecting Nareit FFO per diluted share of $2.70 and Core FFO of $2.77, reflecting 6-7% growth. PECO acquired $181.8 million in assets during the quarter and maintains high occupancy rates above 95%, signaling robust demand. The company also secured a $350 million unsecured term loan to refinance debt and support future growth, positioning it well for 2027 and beyond.

Phillips Edison & Company reported a net income of $62.7 million for Q3 2026, highlighting its strong financial performance. For readers following the Real Estate sector, here is Pluang's market snapshot as of Oct 27, 2026 03:21 WIB: Among 47 priced US Real Estate stocks, 31 rose and 15 fell. Notable movers include Orion Office REIT Inc (ONL) at USD 2.25 with a 1-day change of +2.74% and a balanced Pluang order activity of 50% Sell / 50% Buy, Digital Realty Trust, Inc. (DLR) at USD 171.50 down -2.73% with 100% Sell orders, and KE Holdings Inc (BEKE) at USD 17.53 up +2.63%.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App